Awards Nomination 20+ Million Readerbase
Indexed In
  • Academic Journals Database
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Ulrich's Periodicals Directory
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
Share This Page
Recommended Webinars & Conferences
Journal Flyer
Flyer image

Jyothy John

Jyothy John

Jyothy John
Department of Pharmaceutical Sciences
Texas Southern University, USA


Currently Dr. Jyothy John is a bioequivalence reviewer at US Food and Drug Administration. (USFDA). Jyothy received her B.S. in Pharmacy and M.S. in Pharmaceutics from Rajiv Gandhi University of Health Sciences, Bangalore, India. She earned her Ph.D. in Pharmaceutical Sciences from College of Pharmacy & Health Sciences, Texas Southern University (TSU), Houston, TX. Her Ph.D. study focused on ‘Effect of drug-drug and drug-herbal interactions on the pharmacokinetics and pharmacodynamics of warfarin". Jyothy's research work has been published in several journals, including the Journal of Bioequivalence & Bioavailability, British Journal of Pharmacology, Journal of Chromatography B, International Journal of Nanomedicine and a book chapter in Intech Open Access. She is a co-inventor of two U.S. patents on pharmaceutical formulations. She then pursued post-doctoral training on an NIH funded project entitled “Development of a Novel Nanoconstruct Based Photothermal Therapy for Tumor Hypoxia” at the Department of Pharmaceutical Sciences at TSU in collaboration with University of Texas at M.D. Anderson Cancer Center, Houston, TX. Jyothy is a registered pharmacist (RPh) and has taught both PharmD and PhD courses at the College of Pharmacy at TSU.

Research Interest

In-vivo bioequivalence studies (both clinical and pre-clinical), Formulation of pharmaceutical drug products to increase the bioavailability, Liquid chromatography-tandem mass spectrometry (LC-MS/MS) method development and validation studies, DIssolution studies, Differential Scanning Calorimetry studies, Zeta Sizer studies, UV-VIS Spectrophotometer studies, Fluorescence Spectrophotometer studies, HPLC-UV, and UPLC studies.